OncoCyte Corporation (OCX) Cash Flow Annual - Discounting Cash Flows
OCX
OncoCyte Corporation
OCX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
Report Filing: 2025-05-12 2025-03-24 2024-04-16 2023-04-12 2022-03-11 2021-03-19 2020-04-28 2019-04-01 2018-04-02 2017-02-27 2016-05-24 2014-12-31 2013-12-31
Net Income/Starting Line -58.2 -60.66 -27.78 -72.9 -64.1 -29.93 -22.43 -15.75 -19.38 -11.17 -8.73 -4.99 -3.5
Cash From Operating Activities -22.74 -20.71 -23.32 -45.57 -35.94 -25.98 -19.71 -11.65 -13.38 -7.52 -4.23 -1.16 -0.71
Depreciation and Amortization 1.72 1.56 1.68 5.22 4.21 1.9 0.351 0.559 0.58 0.387 0.283 0.281 0.277
Deferred Income Tax 0 0 0 0 -9.26 -1.25 0.483 0.956 4.38 0 0.065 0 -0.326
Stock Based Compensation 1.58 1.91 6.57 10.04 6.84 5.07 3 1.48 1.63 0.922 1.81 0.318 0.326
Other Non-Cash Items 34.49 37.79 0.174 14.01 28.57 -2.16 0.437 0.118 0.083 1.7 0.018 0.291 0.326
Changes in Working Capital -2.18 0 -3.97 -1.94 -2.2 0.399 -1.55 0.993 -0.686 2.34 2.33 3.22 2.18
Accounts Receivable -3.38 -1.13 0.109 -0.575 -1.23 -0.182 0 0 0 0 0 0 0
Inventory -0.459 -0.41 0 0 0 0 0 0 0 0 0 0 0
Accounts Payable 0.436 0.967 -4.76 0.297 -1.35 0.854 0.741 1 -0.048 0.229 1.04 0.291 0.048
Deferred Revenue 0.275 0 0.677 -1.66 0.373 -0.273 -2.3 -0.009 -0.638 2.11 1.28 2.93 2.13
Other Working Capital 0.949 0.572 0 0 0 0 0 0 0 0 0 0 0
Cash From Investing Activities -0.795 -0.512 -0.932 -4.34 -13.96 -11.75 -12.41 -0.031 0.843 -0.181 0.315 1.32 -0.025
Investments in Property Plant and Equipment -0.19 -0.516 -0.281 -4.34 -2.25 -1.23 -0.918 -0.031 -0.091 -0.106 -0.5 -0.009 -0.025
Payments for Acquisitions 0 0 0 0 -11.71 -10.51 -11.24 0 0 0 0 0 0
Purchases of Securities 0 0 0 0 0 -4 -11.24 0 0 0 0 0 0
Sales and Maturities of Investments 0 0 0.367 0 0 4 11.24 0 0.934 0 0.815 1.33 0
Other Investing Activities -0.605 -0.512 -1.02 -4.34 -13.35 -0.007 -0.252 -0.24 0.934 -0.075 0.815 1.33 0
Cash From Financing Activities 48.99 20.43 12.19 35.81 78.36 22.8 47.87 12.11 9.97 9.88 11.65 0 0
Debt Repayment -0.168 -0.201 -0.117 -1.43 -1.53 0.695 1.36 -1.18 1.58 -0.114 0 0 0
Common Stock Issued 26.44 27.81 13.85 32.84 77.99 20.8 48.85 13.59 8.38 10.55 11.65 0 0
Common Stock Repurchased -5.39 0 -1.12 0 -0.239 -0.014 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 -0.096 0 0 0 0 0
Other Financing Activities 37.25 -5.81 -1.54 4.39 2.15 1.31 -2.35 -0.201 8.38 -0.555 0.004 0 0
Effect of Forex Changes on Cash 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Change in Cash 23.47 -0.796 -12.07 -14.1 28.46 -14.93 15.74 0.434 -2.57 2.18 7.74 0.156 -0.735
Cash at Beginning of Period 9.26 11.13 23.2 37.3 8.84 23.77 8.03 7.6 10.17 8 0.257 0.101 0.836
Cash at End of Period 32.73 10.34 11.13 23.2 37.3 8.84 23.77 8.03 7.6 10.17 8 0.257 0.101
Free Cash Flow -22.93 -21.23 -23.61 -49.91 -38.19 -27.21 -20.63 -11.68 -13.48 -7.63 -4.73 -1.17 -0.735
Operating Cash Flow -22.74 -20.71 -23.32 -45.57 -35.94 -25.98 -19.71 -11.65 -13.38 -7.52 -4.23 -1.16 -0.71
Capital Expenditure -0.19 -0.516 -0.281 -4.34 -2.25 -1.23 -0.918 -0.031 -0.091 -0.106 -0.5 -0.009 -0.025
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us